Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: Animal experiments and clinical study

Journal of Infectious Diseases

Volumn 186, Issue 3, 2002, Pages 379-388

  Mayer, J ^a   Doubek, M ^a   Doubek, J ^b   Horky D ^c   Scheer, P ^b   Stepanek M ^b  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MAGNESIUM ION; POTASSIUM ION; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HYDRATION; KIDNEY CONCENTRATING CAPACITY; KIDNEY DISTAL TUBULE; KIDNEY TUBULE DAMAGE; MAGNESIUM URINE LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SODIUM URINE LEVEL;

ACETYLGLUCOSAMINIDASE; AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CREATININE; HUMANS; KIDNEY DISEASES; MAGNESIUM; MALE; MICROSCOPY, ELECTRON, SCANNING; MYCOSES; POTASSIUM; RATS; RATS, WISTAR; SODIUM; SPECIFIC PATHOGEN-FREE ORGANISMS; STATISTICS, NONPARAMETRIC; WATER-ELECTROLYTE BALANCE;

EID: 0036681666     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341662     Document Type: Article

References (42)

1. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
2. Experience with amphotericin B
3. Amphotericin B toxicity: Changes in renal function
4. Amphotericin B renal toxicity in the dog
5. Vasopressin resistant nephrogenic diabetes insipidus: A result of amphotericin B therapy
6. Renal magnesium wasting associated with amphotericin B therapy
7. Mortality and costs of acute renal failure associated with amphotericin B therapy
8. Hypokalemic paralysis induced by amphotericin B
9. Renal tubular acidosis due to amphotericin B
10. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis
11. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation
12. Amphotericin B nephrotoxicity in humans decreased by salt repletion
13. Effect of salt supplementation on amphotericin B nephrotoxicity
14. Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: Randomised controlled trial
15. Pharmacodynamics of amphotericin B in a neutropenic-mouse disseminated-candidiasis model
16. A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients
17. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
18. Amphotericin B lipid complex for invasive fungal infections: Analysis of safety and efficacy in 556 cases
19. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
20. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis
21. Improvement of cis-dichlorodiammineplatinum (NSC 119875) therapeutic index in an animal model
22. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure
23. High dose cis-platinum diamine dichloride amelioration of renal toxicity by mannitol diuresis
24. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents
25. Must we really fear toxicity of conventional amphotericin B in oncological patients?
26. Urine N-acetyl-β-D-glucosaminidase: A marker of tubular damage?
27. NAG (N-acetyl-β-D-glucosaminidase): A sensitive marker for renal dysfunction
28. Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system
29. Amphotericin B toxicity. Changes in renal morphology
30. N-acetyl-β-D-glucosaminidase (NAG) and alanine aminopeptidase (AAP) excretion after acute administration of acetaminophen, salsalate and aspirin in rats
31. Increase by NO synthase inhibitor of lead-induced release of N-acetyl-β-D-glucosaminidase from perfused rat kidney
32. Inhibition by lithium and rubidium of gentamicin-induced release of N-acetyl-β-D-glucosaminidase from perfused rat kidney
33. Direct vasoconstriction as a possible cause for amphotericin B-induced nephrotoxicity in rats
34. An audit of the use of antifungal agents
35. Amphotericin B use in a major acute care hospital
36. Chronic amphotericin B nephrotoxicity in the rat, protective effect of prophylactic salt loading
37. Chronic amphotericin B nephrotoxicity in the rat: Protective effect of calcium channel blockade
38. Pentoxifylline in amphotericin B toxicity rat model
39. Potassium
40. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus
41. The renal pathology in clinical trials of cis-platinum (II) diamminedichloride
42. Fluid balance in sepsis: Are we ready for a negative balance?